noun. a novel antidepressant substance with an altered tricyclic structure which, not like most antidepressants, enhances instead of inhibits, the presynaptic reuptake of serotonin and thereby decreases serotonin neurotransmission. Its effectiveness compares well to presently utilized antidepressants, and it is being investigated for clinical employment within the U.S. French brand name: Stablon.
TIANEPTINE: “The doctor has prescribed a medication called Tianeptine.”